🕵️ GAIN Therapeutics, Inc. ($GANX)
SEC insider & ownership activity, last 12 months · CIK 1819411 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 16, 2026 | filing ↗ |
| Other events (8.01) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 18, 2026 | filing ↗ |
| Other events (8.01) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Other events (8.01) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 14, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 6, 2025 | filing ↗ |
| Other events (8.01) | Oct 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |